Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.84 +0.02 (+2.51%)
At close: Sep 11, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Interest Coverage Ratio (2020 - 2026)

Rani Therapeutics Holdings (RANI) posted Interest Coverage Ratio of 1103.5 for Q2 2026, down 1064.5% on a QoQ basis from 94.76 in Q1 2026, and down 9112.47% year-over-year from 12.24 in Q2 2025.

Analysis

Rani Therapeutics Holdings (RANI) Interest Coverage Ratio (2020 - 2026) Analysis & Trends

Rani Therapeutics Holdings has reported Interest Coverage Ratio for 7 years, with the latest figure at 1103.5 in Q2 2026.

  • On a quarterly basis, Interest Coverage Ratio fell 9112.47% year-over-year to 1103.5 in Q2 2026; TTM through Jun 2026 was 28.22, a 145.16% decrease from a year earlier, with the FY2025 full-year figure at 13.25, down 25.1% from the prior year.
  • Interest Coverage Ratio was 1103.5 for Q2 2026 at Rani Therapeutics Holdings, down from 94.76 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 8.82 in Q3 2024, with the low at 1103.5 in Q2 2026.
  • Average Interest Coverage Ratio over 5 years is 88.95, with a median of 13.44 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Interest Coverage Ratio jumped 81.62% in 2022, then tumbled 9112.47% in 2026.
  • Over 5 years, Interest Coverage Ratio stood at 24.31 in 2022, then surged by 57.37% to 10.37 in 2023, then dropped by 28.38% to 13.31 in 2024, then tumbled by 84.83% to 24.6 in 2025, then plunged by 4386.4% to 1103.5 in 2026.
  • The last three Interest Coverage Ratio figures came in at 1103.5 (Q2 2026), 94.76 (Q1 2026), and 24.6 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 5.22
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -42.08
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 117.59
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 493.00
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 2.82
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Rani Therapeutics Holdings 157.97 Mn 157.97 Mn - -1,103.50
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,103.50
Mar 31, 2026 -94.76
Dec 31, 2025 -24.60
Sep 30, 2025 -10.01
Jun 30, 2025 -11.98
Mar 31, 2025 -12.74
Dec 31, 2024 -13.31
Sep 30, 2024 -8.82
Jun 30, 2024 -9.82
Mar 31, 2024 -10.85
Dec 31, 2023 -10.37
Sep 30, 2023 -13.57
Jun 30, 2023 -14.45
Mar 31, 2023 -13.68
Dec 31, 2022 -24.31
Sep 30, 2022 -46.43
Dec 31, 2021 13,362.00
Sep 30, 2021 -252.55
Jun 30, 2021 -31.11
Mar 31, 2021 -27.65